HOOKIPA Pharma Inc. (HOOK)
OTCMKTS · Delayed Price · Currency is USD
1.150
+0.010 (0.88%)
Inactive · Last trade price on Jun 2, 2026
HOOKIPA Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -73.31 | -43.5 | -81.58 | -64.92 | -75.67 | -44.08 |
Depreciation & Amortization | 2.5 | 2.75 | 3.55 | 3.6 | 4.64 | 4.15 |
Asset Writedown & Restructuring Costs | 4 | 4 | 12.77 | - | - | - |
Stock-Based Compensation | 1.91 | 2.01 | 2.35 | 5.04 | 7.64 | 8.66 |
Other Operating Activities | 0.04 | - | 0.06 | 0.16 | 1.23 | 0.05 |
Change in Accounts Receivable | 9.74 | 0.52 | 6.18 | -0.34 | -1.94 | -3.58 |
Change in Accounts Payable | -8.1 | -1.57 | 6.5 | -2 | 0.86 | 6.3 |
Change in Unearned Revenue | -2.72 | -27.54 | -8.26 | 35.51 | 1.42 | 0.51 |
Change in Other Net Operating Assets | 13.18 | -13.66 | 0.91 | 2.95 | -4.2 | -11.35 |
Operating Cash Flow | -52.77 | -76.98 | -57.52 | -20 | -66.02 | -39.34 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Capital Expenditures | -0.1 | -0.19 | -4.16 | -5.02 | -12.58 | -2.37 |
Investing Cash Flow | -0.1 | -0.19 | -4.16 | -5.02 | -12.58 | -2.37 |
Financing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Long-Term Debt Repaid | - | -1.14 | -1.75 | -2.85 | -0.44 | -1.42 |
Net Debt Issued (Repaid) | -1.14 | -1.14 | -1.75 | -2.85 | -0.44 | -1.42 |
Issuance of Common Stock | - | - | 49.04 | 45.69 | 0.2 | 42.64 |
Other Financing Activities | - | -0.14 | -0.15 | -0.2 | - | -0.22 |
Financing Cash Flow | -1.14 | -1.28 | 65.67 | 72.27 | -0.24 | 73.42 |
Net Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Foreign Exchange Rate Adjustments | 1.53 | 0.81 | 0.09 | -0.73 | 2.57 | -2.11 |
Net Cash Flow | -52.48 | -77.64 | 4.08 | 46.53 | -76.27 | 29.6 |
Free Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | -52.87 | -77.17 | -61.68 | -25.01 | -78.6 | -41.71 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -565.37% | -175.61% | -306.44% | -175.55% | -426.05% | -212.98% |
Free Cash Flow Per Share | -4.22 | -6.16 | -6.53 | -3.82 | -23.94 | -16.02 |
Levered Free Cash Flow | -32.81 | -49.51 | -39.97 | -31.83 | -55.19 | -29.82 |
Unlevered Free Cash Flow | -32.81 | -49.51 | -39.77 | -31.4 | -54.63 | -29.33 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash Interest Paid | 0 | 0 | 0.01 | 0.03 | 0.05 | 0.1 |
Cash Income Tax Paid | 0 | 0 | 0.4 | 0 | 0 | - |
Change in Working Capital | 12.09 | -42.25 | 5.33 | 36.11 | -3.86 | -8.12 |